The drug is prescribed and used for primary and secondary carnitine insufficiency in adult patients and children, including infants and newborns, carnitine deficiency in patients with end-stage renal failure who are on hemodialysis.
active substance: levocarnitine;
1 ampoule (5 ml) of solution for injection contains 1 g of levocarnitine;
1 ml of solution for injection contains 200 mg of levocarnitine;
Excipients: dilute hydrochloric acid, water for injections.
Solution for injection.
Metacartin belongs to a group of drugs that are used to correct metabolic processes.
The main component of the drug is levocarnitine, a natural substance found in microorganisms, animal tissues, and plants. In humans, the need for levocarnitine is replenished by eating food products containing the component (primarily meat).
The drug Metacartin takes part in many energy processes, oxidizes fatty acids, amino acids, carbohydrates and ketone bodies, also plays an important role in cardiac metabolism, normalizes both fat and protein metabolism, restores the alkaline blood reserve, and also increases exercise tolerance and motor activity. activity.
The drug is prescribed and used for primary and secondary carnitine insufficiency in adult patients and children, including infants and newborns, carnitine deficiency in patients with end-stage renal failure who are on hemodialysis. Also, the solution is indicated for male infertility (azoospermia, oligospermia), disorders of myocardial metabolism against the background of coronary heart disease (postinfarction period, acute myocardial infarction), cardiomyopathy, as well as for chronic and acute disorders of cerebral circulation.
The use of the drug is contraindicated in the presence of individual intolerance to the components of this drug.
The drug can be used in children.
Application during pregnancy and lactation
It is possible to use the drug Metakartin for women during pregnancy, as well as during lactation, as a last resort, only if the intended benefit to the mother significantly outweighs the potential risk to the fetus or child.
Method of administration and dosage
Metacartin is intended for oral use.
At the beginning of treatment, the daily dose for adults and children over the age of 12 years is 2 g (1 bottle), depending on the tolerance of the drug, as well as taking into account the physical activity during the course of treatment, the dose is gradually increased.
The recommended dose is 2-6 g of the drug (1-3 bottles) per day, which is divided into several doses.
For children under the age of 12, the doctor determines the dose according to the age and weight of the child. Usually the dose at the beginning of treatment is 50 mg per kg of the child’s weight once a day, which is divided into several doses. If there is such a need, the dose is increased.
It is necessary to take the solution at regular intervals, regardless of food. If desired, Metacartin can be diluted with fruit juice or water.
No cases of drug overdose were observed. The use of the drug in large doses can lead to the development of diarrhea. In this case, symptomatic treatment is necessary.
Long-term use of Metacartin can cause mild intestinal and stomach discomfort, vomiting, nausea, diarrhea and abdominal pain, but these side effects are temporary and gradually disappear. Often, lowering the dose will correct or reduce gastrointestinal disturbances. The manifestation of allergic reactions is also possible.
Storage conditions and periods
It is necessary to store the drug at a temperature not exceeding + 25 ° C, in its original packaging, out of sight of children. The shelf life of this product is 3 years.